Chikungunya France 2026: Symptoms, Vaccine and Travel Advice for Tourists

Chikungunya cases have been reported in France in 2026. Find out how the virus spreads, symptoms to watch for, mosquito bite prevention and current UK vaccine advice.

Chikungunya cases in France prompt fresh advice for travellers

Travellers heading to France and other destinations where chikungunya is circulating are being encouraged to take sensible precautions against mosquito bites.

The mosquito-borne viral infection can cause a sudden fever and intense joint pain. Although most people recover, symptoms can sometimes continue for weeks or much longer.

According to the latest European Centre for Disease Prevention and Control surveillance available on 19 August 2026, France had recorded 25 locally acquired chikungunya cases during 2026. The cases were associated with three clusters, two of which remained active at that point.

The figures are considerably lower than the previous year, but health authorities continue to monitor the situation because warmer conditions can support the mosquitoes that transmit the virus.

For anyone travelling to France, particularly areas where local transmission has been identified, understanding how chikungunya spreads and how to reduce mosquito exposure can help lower the risk.

What is chikungunya?

Chikungunya is a viral infection transmitted primarily through bites from infected Aedes mosquitoes. These mosquitoes include Aedes aegypti and Aedes albopictus, commonly known as the Asian tiger mosquito.

Unlike some infections that are mainly associated with nighttime mosquito activity, the mosquitoes that transmit chikungunya can bite during daylight hours. This means travellers should not rely solely on mosquito protection while sleeping.

The virus is found in tropical and subtropical parts of Africa, Asia and the Americas. In recent years, locally acquired transmission has also been detected in parts of Europe.

France has experienced locally acquired chikungunya transmission before, and surveillance has continued as mosquito populations capable of spreading the virus have become established in parts of Europe.

Where has chikungunya been detected in France?

The latest ECDC report covering data through 19 August 2026 identified locally acquired cases in France, including clusters in Gironde and Tarn.

Prignac-et-Marcamps in Gironde accounted for the largest active cluster, with 16 cases. Another active cluster was identified in Saint-Amans-Soult in Tarn, while a separate case in Saint-Médard-en-Jalles was classified as a closed cluster.

Travel advice can change quickly during mosquito-borne disease outbreaks. Travellers should therefore check destination-specific guidance shortly before departure rather than relying on information published several months earlier.

The UK's National Travel Health Network and Centre, known as NaTHNaC, continues to publish updates relating to chikungunya outbreaks and travel health recommendations.

What are the symptoms of chikungunya?

Chikungunya commonly begins several days after an infected mosquito bite. The World Health Organization says symptoms can appear between two and 12 days after infection, with four to eight days being typical.

The most characteristic symptoms include:

• Sudden fever
• Severe joint pain
• Swollen joints
• Muscle pain
• Headache
• Tiredness
• Nausea
• Skin rash

The joint pain can be particularly uncomfortable and, in some people, can persist well beyond the initial illness. WHO notes that joint symptoms can occasionally last for weeks, months or even years.

Most infected people recover fully. However, complications involving the eyes, heart or nervous system have occasionally been reported. Babies, older adults and people with certain underlying health problems can face a greater risk of severe illness.

Anyone who develops significant symptoms after visiting an area where chikungunya is circulating should seek medical advice and mention their recent travel history.

How can travellers protect themselves?

Avoiding mosquito bites remains one of the most important ways to reduce the risk of chikungunya.

Travellers can take several practical steps:

Use insect repellent

Apply an effective insect repellent to exposed skin and follow the product instructions carefully. Reapply it as directed, particularly after swimming or heavy sweating.

Cover exposed skin

Long-sleeved tops, trousers and socks can reduce the amount of skin available for mosquitoes to bite.

Consider accommodation carefully

Where possible, choose accommodation with air conditioning, screened windows or doors, or other measures designed to keep mosquitoes outside.

Use mosquito nets when appropriate

If sleeping in accommodation without adequate screening, an insecticide-treated mosquito net can provide an additional layer of protection.

Remove standing water

Aedes mosquitoes can breed in relatively small amounts of stagnant water. Containers, buckets, plant pots and other objects that collect rainwater can provide breeding sites.

Is there a chikungunya vaccine in the UK?

Yes. Two chikungunya vaccines are licensed for use in the UK, IXCHIQ and Vimkunya. However, vaccination is not automatically recommended for everyone travelling abroad.

Current JCVI advice says chikungunya vaccination may be considered for people travelling to areas experiencing active outbreaks, as well as long-term or frequent travellers visiting regions where chikungunya transmission has occurred in recent years.

Importantly, the rules surrounding the vaccines have changed during 2026.

Vimkunya may be offered to people aged 12 and above when vaccination is considered appropriate. IXCHIQ, which is a live attenuated vaccine, is currently limited to immunocompetent adults aged 18 to 59 under UK advice.

The Medicines and Healthcare products Regulatory Agency has also introduced restrictions on IXCHIQ following a safety review. The vaccine should not be used in people aged 60 or over or in people with certain medical conditions, including hypertension, cardiovascular disease, diabetes or chronic kidney disease.

This makes professional travel health advice particularly important. A pharmacist, GP or specialist travel clinic can assess the destination, length of stay, individual circumstances and current vaccine recommendations.

Should you be worried about travelling to France?

The presence of chikungunya cases does not mean that travellers should automatically cancel a trip to France.

The number of locally acquired cases reported in mainland France in 2026 remains relatively limited, although active clusters demonstrate that local transmission can occur. ECDC continues to monitor the situation and notes that environmental conditions in affected areas can support mosquito activity and virus transmission.

The most sensible approach is preparation rather than panic.

Before travelling, check the latest destination-specific advice, pack suitable insect repellent and clothing, and consider whether a travel health appointment is appropriate for your trip.

Final advice for UK travellers

Chikungunya remains primarily a mosquito-borne disease, meaning simple bite-avoidance measures can play an important role in prevention.

If you are travelling to France or another destination where chikungunya is currently circulating, check the latest health information before departure. Do not assume that vaccination is necessary solely because cases have been reported. Likewise, do not assume that a vaccine is suitable for you without discussing your circumstances with a qualified healthcare professional.

For the latest UK travel health information, consult NaTHNaC's TravelHealthPro service and current government guidance before you leave.

Sources

• European Centre for Disease Prevention and Control, Seasonal surveillance of chikungunya virus disease in the EU/EEA, Week 34, 2026.
• UK Department of Health and Social Care, Joint Committee on Vaccination and Immunisation, Chikungunya vaccine in UK travellers.
• UK Medicines and Healthcare products Regulatory Agency, IXCHIQ Chikungunya vaccine: updates to restrictions of use following safety review.
• National Travel Health Network and Centre, Chikungunya travel health information.
• World Health Organization, Chikungunya.

Disclaimer: This article is intended for general information and does not constitute medical or travel-health advice. Chikungunya risks, outbreak information and vaccine recommendations can change. Travellers should check the latest official guidance and speak with a qualified healthcare professional or travel clinic for advice tailored to their destination and personal circumstances.